Testing effectiveness (Phase 2)Study completedNCT00004584
What this trial is testing
Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment
Who this might be right for
HIV Infections
Bristol-Myers Squibb